Publication of data from WIL-31 study marks a milestone in improving long-term care for patients with severe von Willebrand disease (VWD)
(Adnkronos) – LACHEN, Switzerland, Jan. 22, 2024 /PRNewswire/ — Octapharma announced today the publication of the results from the clinical study WIL-31, which investigated the efficacy and safety of prophylaxis with wilate®,
